Tandem Diabetes Care, Inc.
TNDM
$1.30 (-7.61%)
1D
1W
3M
1Y
5Y
ALL
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 9 days ago • TNDM
Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Zacks Investment Research • 13 days ago • TNDM
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?
Business Wire • 13 days ago • TNDM
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
Zacks Investment Research • 13 days ago • TNDM
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
Zacks Investment Research • 14 days ago • TNDM
3 Stocks to Invest in as Broker Rating Upgrades Signal Upside
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.